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Abstract
Caloric restriction (CR) and chemical agents, such as resveratrol and rapamycin that partially mimic the CR effect, can delay
morbidity and mortality across a broad range of species. In humans, however, the effects of CR or other life-extending
agents have not yet been investigated systematically. Human maximal lifespan is already substantially greater compared to
that of closely related primate species. It is therefore possible that humans have acquired genetic mutations that mimic the
CR effect. Here, we tested this notion by comparing transcriptome differences between humans and other primates, with
the transcriptome changes observed in mice subjected to CR. We show that the human transcriptome state, relative to
other primate transcriptomes, does not match that of the CR mice or mice treated with resveratrol, but resembles the
transcriptome state of ad libitum fed mice. At the same time, the transcriptome changes induced by CR in mice are enriched
among genes showing age-related changes in primates, concentrated in specific expression patterns, and can be linked
with specific functional pathways, including insulin signalling, cancer, and the immune response. These findings indicate
that the evolution of human longevity was likely independent of CR-induced lifespan extension mechanisms. Consequently,
application of CR or CR-mimicking agents may yet offer a promising direction for the extension of healthy human lifespan.
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Introduction
Humans stand out among primates not only with respect to
cognitive abilities, bipedal locomotion, and tool production, but
also with respect to maximal lifespan. During mammalian
evolution, longevity has increased independently along multiple
lineages, but one of the most drastic lifespan extensions can be
observed in the lineage that includes humans [1,2]. Human
average lifespan in pre-modern settings was already twice as long
as that of our closest living relative, the common chimpanzee [3].
Among wild chimpanzees, life expectancy at birth is ,15 years of
age, and 90% of individuals die before the age of 40 [4]. Even in
captivity, chimpanzees rarely reach 50 years of age [5,6]. By
contrast, life expectancy at birth among human hunter-gatherers is
30–40 years, and 10–30% reach their 70th birthday [3,7,8]. It has
been hypothesized that the delay in human aging-related mortality
evolved in parallel with a longer developmental period, which itself
may have resulted from selection for an extended learning period
and resource sharing abilities [4,9,10].
The molecular changes that caused delayed mortality and
extended lifespan in humans remain unknown (reviewed in [11]).
Diverse physiological processes can affect mortality and age-
related functional decline, including energy and lipid metabolism,
the immune response, and DNA damage repair, among others
[12–15]. Genetic, environmental and pharmaceutical interven-
tions directed at these and other processes have been shown to
dramatically alter maximal lifespan of laboratory species by as
much as 10-fold [16].
Of these interventions, one of the best-studied is caloric
restriction (CR). CR, a form of dietary restriction, refers to
reducing daily calorie intake by 10–40% compared to unrestricted
(ad libitum) food intake. A key feature of the CR effect is its
evolutionary conservation: CR was shown to extend maximal
lifespan and/or delay morbidity in various taxa including yeast,
nematode worms, fruit flies, rats, and even macaques [17–24]. For
instance, in rodents and primates, CR has been shown to reduce
the risk of several aging-associated disorders including cardiovas-
cular disease, neurodegenerative disease, diabetes, and cancer (e.g.
[18,25–29]).
CR is a versatile intervention that alters the expression levels of
hundreds of genes involved in a variety of biological processes,
such as growth, sugar and lipid metabolism, the immune system,
as well as the oxidative stress response and damage repair [19,30].
The molecular effects induced by CR substantially overlap with
the two major pathways linked with lifespan regulation in model
organisms: insulin/insulin-like growth factor (IGF) signaling and
target of rapamycin (TOR) signaling [31]. Pharmaceutical agents
affecting these pathways and thus mimicking the CR effect can
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affect morbidity and lifespan in model organisms [32]. One such
agent is resveratrol, a polyphenol found in grapes, that can
improve health in aged mammals, including increased insulin
sensitivity and cardiac function [33,34]. Resveratrol treatment can
also increase survival in mice on a high-fat diet [33], although not
on a standard diet [36]. The phenotypic and molecular effects of
resveratrol partially overlap with those seen in CR mice [34].
Another agent, rapamycin, inhibits TOR signaling similar to the
effect of CR in model organisms [32]. In mice, treatment with
rapamycin results in 9–14% life extension without any decrease in
calorie intake [35].
Given the powerful influence of CR on longevity, it is possible
that the evolutionary extension of human longevity involved
genetic changes mimicking the physiological effect of CR, even at
a well-nurtured state. Supporting this possibility, mutations
affecting genes in the IGF signaling pathway, such as transcription
factor FOXO1A, are associated with longevity among humans [36].
Further, it was reported that FOXO1 is transcribed at higher levels
in humans compared to chimpanzees [37]. Insulin and IGF levels
were also reported to be higher in male chimpanzees compared to
male humans [38]. If such changes did contribute to human
longevity, a CR-like signature, at least in some physiological
processes, should be detectable among gene expression changes
separating humans from closely related shorter-lived primates:
chimpanzees and macaques.
This hypothesis can be tested by comparing gene expression
changes induced by CR and resveratrol in the mouse system with
gene expression changes separating humans from chimpanzees
and macaques, across multiple tissues and ontogenetic time
intervals. In recent years, a number of studies have published
mouse transcriptome data suitable for such an analysis (Table 1).
One experiment used 14-month old mice subjected to 70% CR or
a resveratrol diet, for 16 months [34]. Mice under both treatments
showed increased health parameters relative to same-aged ad
libitum-fed (AL) controls. Importantly, the authors reported
significant correlation in gene expression changes induced by
CR and resveratrol treatments, in both neocortex and heart tissue.
Another study compared liver gene expression in 6 month-old
mice subject to 70% CR and long-lived dwarf mice [39]. The
authors found limited overlap between the two models’ expression
profiles, but common changes indicating increased insulin
sensitivity in CR and in dwarf mice, relative to wild-type AL
controls. The third study included middle-aged mice fed on a
high-calorie diet (60% of calories derived from fat) for 6-months,
mice on a similar diet but supplemented with resveratrol, and
control mice [33]. This showed that resveratrol can improve
overall health and survival under the high-calorie diet. Notably,
liver gene expression changes observed in high calorie-fed mice
were slowed down by resveratrol treatment. The authors also
noted similarities between resveratrol-induced changes in high
calorie-fed mice, and caloric restriction-induced liver expression
changes observed in another experiment. Together, these datasets
provide sufficient material to test the hypothesis that gene
expression differences between humans and other primates could
partly resemble CR-induced transcriptomic changes, such as lower




We collected postmortem samples of prefrontal cortex, heart
and liver tissue from humans (n = 15), chimpanzees (n = 15) and
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healthy adult males. The human samples were obtained from
NICHD Brain and Tissue Bank for Developmental Disorders
(NICHDBB) (Baltimore, MD, USA), the chimpanzee samples
were obtained from the Yerkes Primate Center (Atlanta, GA,
USA), the Biomedical Primate Research Center (Rijswijk, Nether-
lands) and from the Anthropological Institute of the University of
Zurich (Swithzerland), and the macaque samples were obtained
from the Suzhou Drug Safety Evaluation and Research Center
(China). Frozen brain samples from male mice were provided by
the animal housing center at the Max Planck Institute for
Evolutionary Anthropology (Germany). All subjects had unre-
stricted access to food, none were obese, and none suffered from
acute metabolic disorders. Mice prefrontal cortex samples were
collected before mRNA isolation.
Ethics Statement
Informed consent for the use of human tissues for research was
obtained in writing from all donors or their next of kin. All non-
human primates used in this study suffered sudden deaths for
reasons other than their participation in this study and without any
relation to the tissue used. All chimpanzees died naturally. All
macaques were involved in a drug testing study as a control group
and were killed by injection with a lethal dose of ketamine. All
non-human primate samples were donated to the study. Biomed-
ical Research Ethics Committee of Shanghai Institutes for
Biological Sciences completed the review of the use and care of
the animals in the research project (approval ID: ER-SIBS-
260802P). All mice were bred, housed, and sacrificed by method of
neck dislocation at the Max Planck Institute for Evolutionary
Anthropology mouse facility.
mRNA extraction, hybridization and data preprocessing
Experimental procedures of mRNA extraction followed [40,41].
Briefly, mRNA from primate samples was hybridized to the
Affymetrix GeneChip Human Exon 1.0 ST Arrays following the
standard Affymetrix protocol. For data processing, we firstly
mapped probes in the Human Exon 1.0 ST Chip to the human
genome (hg18), chimpanzee genome (panTro2.1) and rhesus
macaque genome (MMUL1.0) separately using Bowtie [42]. We
then masked out probes that could not match perfectly and
uniquely to any of the respective genomes. To exclude probes with
signal intensities below background noise, we compared each
probe’s intensity to the distribution of anti-genomic probe
intensities with the same GC content (the latter are designed to
detect non-specific hybridization). A ‘‘detectable’’ probe was
defined as one with intensity larger than the 95% percentile of
the anti-genomic probes’ intensities (comparing only to those anti-
genomic probes with the same GC content). Detectable probe
intensity values were log2 transformed and quantile normalized. If
a transcript had more than 10 detected probes, we called this a
detectable transcript. Affymetrix’s Transcript Cluster Annotation
file was used to map transcript clusters to Ensembl Genes (v.54).
For mouse, mRNA was hybridized to Mouse Gene 1.0 ST Arrays
following the same data processing procedure described above. A
transcript was called detectable if it had more than 7 detected
probes. All data is deposited in the NCBI Gene Expression
Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/)
with ID GSE44147.
Public data collection and processing
We searched the GEO database for gene expression data from
caloric restriction experiments using mice, as well as gene
expression data from human, chimpanzee and rhesus macaque.
In total, we collected 6 datasets, which included information about
three tissues: cerebral cortex, liver, and heart (Table 1). Expression
profiles from each experiment were downloaded from GEO and
processed following the authors’ description. To facilitate
comparison across species and across datasets, we used the
following procedures: (1) all mouse and human gene expression
datasets were annotated using mouse and human Ensembl (v.54)
gene IDs, respectively, (2) mouse Ensembl gene IDs were mapped
to human Ensembl gene IDs, using one-to-one human-mouse
orthologous gene pairs defined by Ensembl (downloaded from the
Ensembl BioMart website; http://www.biomart.org). Microarray
expression data was preprocessed and summarized based on
Ensembl genes, using the R [43] ‘‘affy’’ library [44] and in-house
code.
Effect size calculation and pair-wise comparisons of diet
and species effects
In order to capture the gene expression differences between two
conditions (e.g. CR vs. ad libitum or human vs. chimpanzee),
Cohen’s d (mean difference between groups normalized by pooled
standard deviation) was used as the effect size measure [45]. For
each dataset, tissue, and gene, we calculated effect size for CR-ad
libitum differences in mice, standard diet-high calorie diet
differences in mice, resveratrol-control differences in mice,
human-chimpanzee differences, or human-rhesus macaque differ-
ences. Next, we compared effect sizes across all detectable
homologous genes between a pair of datasets (diet/resveratrol
effect versus species difference effect) involving the same tissue,
using the Pearson’s correlation test (Figure 1). To test whether
significant positive Pearson correlations (at p,0.05) between the
diet/resveratrol effect versus the species difference effect occur
more than expected by chance among the multiple datasets, we
first used a binomial test. Because the comparisons are not
independent, we further estimated the significance and false
discovery rate (FDR) of this overall correlation using permutations.
We used the following procedure: (1) we shuffled the species or
treatment labels in each of the diet/resveratrol or species datasets;
(2) for each shuffled dataset, we re-calculated the effect size with
the same method as described above; (3) we calculated the
correlations between each pair of shuffled datasets (diet/resvera-
trol versus species effect) involving the same tissue. This procedure
was repeated 100,000 times. Finally, we calculated the significance
of the number of positively correlated comparisons (r.0 and
p,0.05) as the frequency among 100,000 permutations where we
found at least as many positively correlated comparisons. We
further calculated the FDR as the ratio between the median
number of positively correlated comparisons among the 100,000
permutations, relative to the observed number of positively
correlated comparisons.
Brain age series data processing
We used an age series dataset [46] to make comparisons of
transcriptome difference between humans and the other two
primates, during postnatal development and in aging, separately.
As subject ages were unevenly distributed across time and among
species, we used interpolated points to compare expression profiles
among species [47]. For interpolation, we fit spline curves with age
to the expression data for each gene, and for each species, using
the R function ‘‘smooth.spline’’ with parameters df = 3. Further-
more, in each case, to model expression changes during aging we
fit regression models using chronological age, and to model
changes during postnatal development we fit regression models
using log-transformed age. Expression changes occur rapidly in
early life and are therefore best modeled using log-transformed
age, whereas expression changes occur slower after sexual
Human Longevity Uncoupled from Caloric Restriction
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Figure 1. Correlations between human-specific gene expression divergence with CR-induced gene expression changes in mice.
Normalized gene expression divergence (effect size) between humans and non-human primates was compared with the normalized expression
difference (effect size) between CR mice and ad libitum-fed (AL) mice in each tissue. A: Bar plot representing the Pearson correlation coefficient
between human and non-human primate differences and the CR effect in heart, cerebral cortex and liver. Each bar represents a comparison, and the
text (e.g. C1::S2) below each bar gives the reference for the data sets used in a comparison (see Table 1). B: Scatter plot of primate species differences
and CR effect in the cerebral cortex. The x-axis represents the effect size for human and non-human differences; the y-axis represents the effect size
for CR and AL differences. Genes with similar CR-AL effect size were binned together to calculate the mean value for each group of genes and the
bars represent the variance of each bin. The significance of the correlations are based on the Pearson correlation test, using all expressed genes.
Pearson correlation coefficients and significance levels are shown inside the panels. H-C AGING: Correlation of human-chimpanzee differences with
the CR effect for the aging period (post-adulthood). H-M AGING: Correlation of human-macaque differences with the CR effect in aging. H-C DEVO:
Correlation of human-chimpanzee differences with the CR effect in postnatal development. H-M DEVO: Correlation of human-macaque differences
with the CR effect in postnatal development. C: Bar plot representing the Pearson correlation coefficient between human and non-human primate
differences and the resveratrol effect in cerebral cortex, heart and liver. Each bar represents a comparison, and the text (e.g. C1::S2) below each bar
gives the reference for the data set used in a comparison (see Table 1). D: Bar plot representing the correlation of human and non-human primate
differences with resveratrol effect in the cerebral cortex for both postnatal development and aging periods. The asterisks indicate correlation
significance levels corrected for multiple testing: *: p,0.05; **: p,0.01; ***: p,0.001.
doi:10.1371/journal.pone.0084117.g001
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maturation, and are best modeled using a linear age scale [41].
Because the three primate species have different rates of
maturation and aging, we used specific age-ranges to compare
their expression profiles: ages 0,20 years for human (n = 12),
0,12 years for chimpanzee (n = 8), and 0,6 years for macaque
(n = 16) were chosen to define the developmental period; ages
20,98 years for human (n= 11), 12,54 years for chimpanzee
(n = 4) and 6,27 years for macaque (n= 10) were chosen to define
the aging period. The ages were chosen to correspond to ages at
first reproduction and physical maturation in non-human primates
[29,48] and humans [49]. To compare between a pair of species
during a specific interval, we compared the interpolated expression
curves in that interval using the same effect size calculation
method. We divided each specific interval (developmental period
or aging period) into 10 subintervals for each species, and used the
interpolated expression values at the 10 evenly distributed age
points to calculate the effect size between a pair of species. Note
that this procedure removes inter-individual expression variation
within species, but expression variation due to age is retained. This
approach further allows straightforward comparison among
species with different developmental and aging rates.
Analysis of CR-affected genes
The Welch’s t-test (without assuming equal variances between
groups) was employed to calculate the significance of expression
differences for each gene between the CR condition and control
(ad libitum) condition, using the R function ‘‘t.test’’. Next, we
performed 1000 permutations of sample labels to estimate the
random significance level of expression difference. We determined
the p-value cutoff at permutation-based false discovery rate (FDR)
,10%, and all genes below this cutoff were defined as CR-affected
genes. Notably, genes with higher expression level tend to have
lower experimental and/or biological noise [50], leading to
ascertainment bias in statistical tests for differential expression:
genes with higher than average expression will have higher
opportunity to pass p-value thresholds. This, in turn, can generate
spurious overlaps when comparing significantly differentially
expressed gene lists. To eliminate such possibility, we also
classified genes into different groups according to their expression
level and did the same analysis as above. We still found that age-
related genes are significantly enriched in CR-affected genes with
both high expression levels and low expression levels (data not
shown). Finally, we used a non-parametric test (Mann-Whitney U
(MWU), using the R ‘‘wilcox.test’’ function) to identify CR-
affected genes, as alternative to the Welch’s t-test. The results were
consistent using either of the two tests. Specifically, we find 5732
CR-affected genes (at FDR ,10%) using the MWU test,
compared to the 5456 genes using the t-test. The two gene lists
show high overlap: 5143. In addition, we confirmed that CR-
affected genes identified using the MWU test are also significantly
enriched in age-related genes (Fisher exact test, p,0.0001), are
enriched in Pattern-2 genes (see below) (Fisher’s exact test,
Bonferroni correction, p=0.012), but are not enriched in
Pattern-1 or Pattern-3 genes (Fisher’s exact test, Bonferroni
correction, p=0.09 and p=1).
Pattern identification for 3 primate species
Polynomial regression models were used to identify age-related
genes and non-age-related genes, as well as to test for pair-wise
species differences in the human, chimpanzee and rhesus macaque
age series data. For each gene, to test for significant age-related
change, we used families of polynomial regression models,
including linear, quadratic and/or cubic terms with individual
age, using the R ‘‘lm’’ function, and tested significance using the
F-test with the R ‘‘anova’’ function [43]. We further tested
significant differences between age-expression trajectories between
a pair of species using ANCOVA with the R ‘‘lm’’ and ‘‘anova’’
functions. We employed a method described in [46] to further
group age-related genes into three patterns, represented in
Figure 2A. Pattern-1: genes changing with age (at F-test p,0.01)
but showing no species difference between any pair of species (at
F-test p.0.1). Pattern-2: genes changing with age (at F-test
p,0.01), and showing significant species differences between at
least one pair of species (at F-test p,0.01) and showing no
difference in developmental expression patterns among three
species (at F-test p.0.1). This latter quality is tested by removing
any constant expression level difference among the species (by
normalizing each species’ expression vector, for each gene, to the
same mean), and then testing for significant differences between
pairs of species. Pattern-3: genes changing with age (at F-test
p,0.01), and also showing a developmental expression pattern
difference among three species (at F-test p,0.01) (i.e. even after
normalizing to the same mean, we find differences between the
expression-age trajectories of different species).
Clustering of expression profiles
We used the k-means method to cluster genes changing with
age, or showing species differences, but not showing expression
pattern differences among the three species (pattern-2 above), into
different sets with similar expression patterns within each set. For
each cluster of genes, we compared the effect size between humans
and chimpanzee/rhesus macaque for these genes, with the effect
size for randomly chosen genes. We then performed 1000
permutations of genes to estimate the significance of difference
for each cluster of genes.
Functional analysis
We used the DAVID Gene Set Enrichment Analysis [51] tool to
test the enriched functions of each group of genes including Gene
Ontology (GO) [52] and Kyoto Encyclopaedia of Genes and
Genomes (KEGG) [53] pathways. Only terms with p-value lower
than 0.05 after Bonferroni correction are reported.
Pathway analysis
Ensembl genes within each KEGG pathway were extracted
using the R CORNA package [54]. We then tested the correlation
between CR effect and species effect across genes within each
pathway. Only pathways with more than 5 genes were tested. We
limited our analysis to human-chimpanzee differences during the
aging period with or without CR, as this was the comparison with
the strongest correlation between species and CR/resveratrol
effects. Pathways with p,0.05 after Bonferroni correction for
multiple testing were reported as significant.
Expression shift analysis of mouse and human
In order to deduce how the timing of physiological changes
matches between human and mouse, we used the dynamic time
warping algorithm developed by Yuan et al. [47]. This can
calculate the time-shift between orthologous genes’ expression
curves from different species, such as human and mouse. We used
the above-described dataset for mouse (Table S1) containing 12
individuals between ages 2 and 904 days. Genes within the mTOR
pathway, as defined in the KEGG database, were obtained using
CORNA [54]; their expression profiles are shown in Table S2. For
human, we used 23 human prefrontal cortex samples (aged
between 0 days and 98 years) published in [46]. We used the
estimated conception age of mouse and human, respectively, for
Human Longevity Uncoupled from Caloric Restriction
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the analysis in order to eliminate the prenatal development
differences between mouse and human. That is, we added 19 days
to mouse and 280 days to human postnatal ages, respectively.
Genes with a correlation of gene expression between the human
and mouse larger than 0.5 were retained for shift analysis. We used
bootstrapping (sampling with replacement) to infer the mean age
of human, and the relative confidence interval, corresponding to a
600 days-old mouse, both for all genes and for genes within the
mTOR pathway, respectively.
Results
Comparison of human-specific and CR-induced
expression changes in adult tissues
To investigate whether physiological differences between
humans and other primates may involve ‘‘CR-like’’ changes in
humans, we first compared CR-induced transcriptomic changes in
mice, with human-specific gene expression patterns (i.e. expression
differences between humans and chimpanzees, or human and
macaques) observed in adult individuals. To do so, we used
publicly available transcriptome data and additionally generated a
novel transcriptome dataset from three primate tissues (Table 1).
We collected the following publicly available datasets: (a) brain,
heart, and liver transcriptome datasets from CR and ad libitum-fed
mice [33,34,39]; (b) liver transcriptome data from mice on a
standard diet and a high calorie diet [45]; (c) adult primate liver
and heart transcriptome datasets [40,55]. In addition, we
generated transcriptome measurements from brain, liver and
heart tissue in a total of 15 human, 15 chimpanzee and 4 rhesus
macaque tissue samples using Affymetrix Exon arrays (Table 1).
Based on these data, we compared gene expression differences
observed between CR and ad libitum-fed mice to gene expression
differences between humans and the two shorter-lived primate
species: chimpanzees and macaques. We found that, relative to the
other two primate species, the human transcriptome was
consistently closer to the transcriptome of ad libitum-fed mice,
rather than CR mice (Figure 1A). The positive correlations
between human-specific and ad libitum-fed transcriptome changes
were observed in all comparisons conducted using brain and heart
datasets, as well as all the comparisons resulting in significant
correlations conducted using liver datasets (Pearson correlation
test, p,0.05) (Figure 1A). Tested across all comparisons, this trend
was highly significant (one-sided binomial test, p,0.0001) and
could be further confirmed using sample permutation analysis
(p=0.0002). These results do not support the notion that human
longevity has been driven by ‘‘CR-like’’ genetic changes affecting
the human transcriptome. Rather, the human transcriptome
corresponds to a ‘‘well-fed’’ mouse phenotype, possibly reflecting
augmented dietary caloric content during human evolution,
relative to the diets of non-human primate species [3,56,57].
Figure 2. Association of the CR effect and age-related changes in brain. A: Simulated examples of expression changes with age: Pattern-1
denotes genes with expression changes with age conserved across species; Pattern-2 denotes genes with a conserved pattern of expression change
with age, but also with significant average expression level differences among species; Pattern-3 denotes genes with developmental expression
pattern differences among species. Points represent individuals; lines represent regression curves for each species. B: Bar plot showing the numbers
of CR-affected and non-CR-affected genes among Pattern 1–3 genes. Fisher’s exact test was used to test the enrichment of CR-affected genes among
genes showing each of the three patterns (based on data set C1 in Table 1). C: Genes within Pattern-2 were grouped into 8 modules (M1-M8) by k-
means clustering based on gene expression patterns across human, chimpanzee and macaque. In the upper row panels the x- and y-axes represent
log2-transformed age and normalized gene expression level, respectively. Colors represent species: red: human; black: chimpanzee; green: rhesus
macaque. The number of genes in each module is shown on top of each figure. In the bottom row panels the x- and y-axes represent CR-AL (ad
libitum) effect size and the density (relative frequency) of the effect size distribution, respectively, for the same gene modules depicted in the upper
row panels. The null distribution of the CR effect (generated by permuting CR labels 1000 times and recalculating effect size, shown in grey) was
compared with the real distribution of CR effect size within each module (purple). The asterisks indicate the significance comparing the distribution of
gene effect size within each module to the permutations. *: p,0.05; **: p,0.01; ***: p,0.001.
doi:10.1371/journal.pone.0084117.g002
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Comparison of human-specific expression changes
across lifetime and CR-induced expression changes
In mammals, a large number of genes change their expression
levels during lifetime, from birth until old age [41]. Since the
above-described analysis only involved adults, we additionally
tested the similarity between the CR state and human-specific
expression changes using published prefrontal cortex time-series
data, where gene expression was measured in 23 human, 12
chimpanzee and 25 rhesus macaque individuals of different age
[46]. Using these data, we compared gene expression differences
induced by CR with gene expression differences between humans
and shorter-lived primate species, chimpanzees and macaques,
during human postnatal development (0–20 years of human age)
and aging (20–98 years of human age). Indeed, we again found
that during both ontogenetic periods the human brain transcrip-
tome, relative to the chimpanzee and rhesus macaque transcrip-
tomes, showed significantly greater similarity to the transcriptome
of ad libitum-fed mice than to that of CR mice (Pearson correlation,
p,0.01) (Figure 1B). Notably, among all comparisons, AL versus
CR differences showed the strongest correlation with human versus
chimpanzee differences during aging. These results further imply
that the lower mortality and higher longevity characteristic of
humans is not caused by the ‘‘CR-like’’ state of the human
transcriptome at any stage of postnatal ontogenesis.
Comparison of human-specific and resveratrol-induced
expression changes
Resveratrol, a natural phenol, has been shown to successfully
increase the survival of mice fed high-calorie diets [33] and to
extend lifespan in several species [33,58,59]. In mice, transcrip-
tional changes under resveratrol have also been reported to mimic
the changes mediated by caloric restriction [60]. We thus asked
how the transcriptional effects of a lifespan-extending drug like
resveratrol may compare with gene expression differences
observed among primate species. To do so, we used results from
two experiments that studied the expression changes induced by
resveratrol in the mouse brain, liver and heart [33,34]. Similar to
the comparison between CR and ad libitum-fed mice, we found that
the human transcriptome, when compared to the transcriptomes
of non-human primates, was more similar to the untreated mice
transcriptome than to the resveratrol-treated mice transcriptome.
This effect was consistent across tissues and observed for all
comparisons conducted in the brain and heart, as well as for three
out of the five comparisons conducted in the liver (Figure 1C). The
trend was highly significant across data sets (one-sided binomial
test p,0.00001, permutation test p=0.0001). We also found
significant correlations in the same direction when comparing the
resveratrol effect to human versus non-human primate differences
during postnatal development or aging (Figure 1D). No compar-
ison showed a significant trend in the opposite direction. This
result demonstrates that transcriptome features separating humans
from shorter-lived primates also do not mimic the changes induced
by resveratrol treatment.
Functional association between CR effect and age-
related changes in primates
Caloric restriction has been shown to retard the aging process
and partially attenuate age-related gene expression changes [61–
63]. In agreement with this observation, we found significant over-
representation of CR-affected genes identified in the mice brain,
among genes undergoing age-related expression changes in the
human prefrontal cortex [41] (Fisher’s exact test, p,0.001)
(Materials and Methods). This association was also valid after
controlling for gene expression level as a potential confounding
factor (Materials and Methods). We further classified age-related
genes found in the human brain into three categories based on the
conservation of their expression profiles among humans, chim-
panzees and rhesus macaques, and following the methodology
suggested elsewhere [46] (Materials and Methods): (Pattern-1)
genes with a developmental expression pattern and conserved
expression level among the three species; (Pattern-2) genes with a
conserved developmental expression pattern, but expressed at
different levels in the three species; and (Pattern-3) genes showing
a developmental pattern difference among the species (Figure 2A).
We found that CR-affected genes are enriched in Pattern-2 genes
(Fisher’s exact test, Bonferroni correction, p=0.019), but not in
Pattern-1 or Pattern-3 genes (Fisher’s exact test, Bonferroni
correction, p=0.06 and p=1) (Figure 2B).
We next focused on Pattern-2 genes to search for specific age-
related expression modules, and their corresponding functional
processes, that overlap with transcriptome changes found in CR.
Using the k-means clustering algorithm, we classified Pattern-2
genes into eight modules based on their prefrontal cortex
expression profiles across the three species (Figure 2C). Three
out of these eight modules, module 1, 5 and 8, showed a significant
correlation between age-related changes found in primates and
expression changes induced by CR (Figure 2C). In agreement with
the general analysis of transcriptome changes described above, in
all three modules the human expression state could be associated
with ad libitum-fed mice, and the chimpanzee and macaque
expression state - with CR mice (Figure 2C).
We then investigated the functional properties of module 1, 5
and 8 genes using Gene Ontology (GO) terms and KEGG
pathways. Module 1 genes were enriched for genes involved in
glycosylation, known to regulate nutrient-mediated signalling [64].
Module 5 genes were enriched in the GO term ‘‘mitochondrion’’,
the site of oxidative metabolism in eukaryotes, which is closely
linked with aging and CR response [23,65,66]. Module 8 genes
were enriched in GO terms associated with the plasma membrane
and synapses – functions also shown to be affected by CR [67]
(Table S3). These results indicate that several pathways associated
with CR effects show the same trajectory of age-related changes in
humans, chimpanzees and macaques, but display expression level
shift in humans in the direction of the ad libitum-fed expression
state.
To further investigate the association between the CR-induced
and the human-specific transcriptome changes at the pathway
level, we tested the correlation in the expression differences
between humans and chimpanzees during brain aging, and the
CR-induced expression changes in the mouse brain, for each of
the KEGG pathways. Notably, the human-chimpanzee compar-
ison during brain aging (relative to comparisons in other tissues,
human-macaque comparisons, and species differences during
postnatal development) had shown the strongest overall correla-
tion between the CR effect and species differences (Figure 1A–B).
Of the 230 KEGG pathways tested, genes in 22 pathways
showed significant positive correlations, indicating similarity
between the human transcriptome and the expression state of
ad-libitum fed mice (Pearson correlation, p,0.05). Notably, these
22 pathways included the insulin signaling, as well as a number of
other functional processes involved in development, cell growth,
cancer, and immunity (Table S4). This is especially interesting
given that insulin signaling is one of the two major pathways
involved in lifespan regulation in multiple species, including
humans [68,69]. Meanwhile, improved immune function and
decreased incidence of cancer are hallmarks of CR in both mice
and primates [14,18]. Notably, no pathway showed negative
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correlations between human versus chimpanzee differences and AL
versus CR differences.
Association between the effect of rapamycin and age-
related changes in primates
The results above suggest that during human evolution, due to
either environmental or genetic effects, human physiology moved
farther away from the physiological states induced by CR- or
resveratrol treatment. This implies that CR or treatments with
CR-mimetics in humans may yet have the potential to induce
transcriptome changes associated with greater longevity. One such
particular treatment involves the suppression of the mammalian
target of rapamycin protein (mTOR) pathway. mTOR signaling
regulates cell growth and cell mortality in response to nutrient
intake [70], and its suppression has been implicated to play a
central role in the CR response [24,71]. Rapamycin, a bacterial
product that interacts directly with the mTOR gene, can increase
lifespan in mice, even when administered at an advanced age, such
as 600 days [35].
The discovery of the life-extending rapamycin effect in mice has
raised the possibility that rapamycin-like therapies administered in
middle-aged humans could also lead to the extension of healthy
lifespan. At what age could such a therapy be successfully
administered in humans? To answer this question, we determined
the physiological age of the human brain that corresponds to the
physiological state of 600 day-old mice, particularly with respect to
gene expression changes in mTOR pathway genes. Specifically,
we calculated the time-shift between human and mouse gene
expression time-series data for all expressed genes, and for genes in
the mTOR pathway, using an optimized dynamic time-warping
algorithm [47]. The transcriptome-wide alignment of human and
mouse expression time-series showed that the brain transcriptomic
state of 600 day-old mice corresponds to the brain transcriptomic
state of a 66-year old human +/21 year (95% bootstrap
confidence interval) (Figure S1). For mTOR pathway genes,
however, the corresponding human age was on average slightly
younger: 62 years +/210 years (95% bootstrap confidence
interval) (Figure 3). Assuming that transcriptome changes in the
brain reflect the rate of overall senescence, this result indicates that
rapamycin-like therapies have a potential to be successfully
introduced in humans at least until 62 years of age.
Discussion
Multiple lines of evidence indicate that CR and CR-mimicking
drugs and mutations can improve health and/or increase maximal
lifespan in a vast variety of species, including mice and macaques
[18,21,22]. At the same time, the maximal lifespan of humans is
already substantially longer than the maximal lifespan of other
primate species, including closely related ones. This has raised the
question whether mutations that shifted human physiology toward
a ‘‘CR-like’’ state may have contributed to lifespan extension
during human evolution.
Here we show that human-specific transcriptome changes are
more similar to the transcriptome of ad libitum-fed mice rather than
CR mice. This result could be replicated in multiple tissues, and
multiple datasets, generated by a number of independent research
groups and observed at different stages of human postnatal
lifespan.
There remains the possibility that some of the mutations
involved in the evolution of human longevity have effects
resembling that of CR, such as improved stress or immune
responses. Nevertheless, because CR can induce massive gene
expression changes in multiple tissues [17,30], we would expect
any substantial contribution of a CR-like physiological change to
human longevity to be detectable in at least some of the human
tissues, or some physiological processes, at the transcriptome level.
Instead, we observe a substantial shift in the human transcriptome
towards ad libitum-fed mice across all the tissues and functional
pathways examined, including insulin signaling, cancer and
immune pathways. Therefore, our observations do not support
the hypothesis postulating that mutations inducing a general CR-
like physiological state, even in the presence of ample nutrition,
contributed to the extended longevity of the human species. Our
results instead may reflect a physiological shift in human tissues
induced by a greater calorie and nutritional content in the average
human diet, compared to the fruit and vegetable-based diets of
chimpanzees and macaques [3,56,57,72].
Figure 3. Time-shift between human and mouse expression profiles in the mTOR pathway. A: mTOR pathway gene expression curves of
human and mouse prefrontal cortex. The x-axis shows log-transformed age from conception (‘‘conception age’’) values for both human and mouse,
and the y-axis shows the normalized gene expression value. Each asterisk represents the mean expression value for a certain age point and horizontal
bars represent the expression variance of genes within the mTOR pathway (only 42 of the 52 genes that showed substantial correlation (Pearson
r.0.5) with the average pathway profile were included). B: Human-mouse time-shift. The x-axis shows the age from conception of mouse, and the y-
axis shows the time-shift of human age relative to mouse age. Each asterisk represents the average time shift of genes within the mTOR pathway, and
the bars show the variance of each time point. C: Scatter plot of human age plotted against mouse age according to the human-mouse time-shift
values. The x- and y-axes show the age from conception of mouse and human, respectively. The red arrow indicates the point where human age
equals 600 days of mouse age based on the time-shift calculation for the mTOR pathway genes.
doi:10.1371/journal.pone.0084117.g003
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These findings also relate to the discussion around whether CR,
or CR-mimicking drugs, such as rapamycin, could significantly
lower morbidity and extend lifespan in humans [73–75]. It has
recently been demonstrated that CR and CR-like effects can
significantly lower mortality in primates by induction of a
physiological state that protects against age-related disease in
various tissues, including liver, heart, and brain [19,21], at least
under certain CR and genetic background conditions [76].
Accordingly, lower calorie intake has been suggested to improve
health and extend lifespan in humans. For example, a six-year-
long application of CR to a set of volunteers was reported to cause
physiological changes that mirror those observed in CR mice,
including lower blood cholesterol and insulin and a reduced risk of
atherosclerosis [77]. Even six months of CR treatment could
improve cardiovascular health in non-obese humans [78]. Another
line of evidence in the same direction is the average longer lifespan
of Okinawans (1.5 years longer than the Japanese average); this
has been attributed to their lower caloric intake (83% of Japanese
average in the 1970’s), in addition to other genetic factors [79].
Finally, mutations in the FOXO1A gene, a key transcription factor
implicated in the CR effect in model species, are among the few
loci associated with variation in human longevity [36], further
implying possible beneficial effects of CR on human health.
However, various researchers have remained skeptical on the
possible effectiveness of CR in extending modern human lifespan
[73]. For example, Shanley and Kirkwood have argued that the
CR response among animals does not have a common origin, and
we should not expect a human response similar to that in model
organisms [80]. Phelan and Rose have pointed out that large
mammals may not respond to energy restriction as intensely as
small ones [81]. This is partly because small mammals allocate a
larger proportion of their resources to reproduction, and under
dietary restriction, this can be efficiently reallocated towards
maintenance and longevity. Accordingly, lifespan extensions seen
in mice may not be observed in large mammals like humans.
Meanwhile, Le Bourg has argued that CR-like responses to limited
food availability would be advantageous for small mammal
lineages, because migrating long distances is not an option for
small species [82]. However, large mammals can migrate in times
of famine, and therefore CR responses would not be selected for.
Our results indicate that humans do not show a transcriptome
state compatible with the CR effect. On the contrary, human
physiology has moved further away from a state shaped by modest
calorie intake that we observe in other primates, including
macaques. As CR can result in significant retardation of aging-
related changes in macaques [21,76], our findings suggest that CR
or CR-mimicking drugs could still have the potential to affect
human physiology toward a substantial extension of healthy
lifespan, and improvements in humans could be more pronounced
even than those seen in macaques.
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